Presentation and Q&A
Back to course
Video Transcription
Video Summary
metabolic comorbidity
severe mental illness
cardiovascular disease
antipsychotic medications
GLP-1 receptor agonists
monitoring metabolic parameters
insurance coverage
lifestyle interventions
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Powered By